New Key Statistics Module, Z-Score and F-Score
SZSE:002099 Key Ratios
Market Cap ¥ M | 8,336.38 |
Enterprise Value ¥ M | 8,079.69 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 1.50 |
Price/Sales | 4.28 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 2,066.00 |
EPS (TTM) ¥ | -0.26 |
Beneish M-Score | -2.68 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -444.20 |
EV-to-EBIT | -18.62 |
EV-to-EBITDA | -18.62 |
PEG | -- |
Shares Outstanding M | 1,618.72 |
Net Margin (%) | -20.79 |
Operating Margin % | -5.74 |
Pre-tax Margin (%) | -23.25 |
Quick Ratio | 1.15 |
Current Ratio | 1.49 |
ROA % (ttm) | -5.19 |
ROE % (ttm) | -7.32 |
ROIC % (ttm) | -1.68 |
Dividend Yield % | -- |
Altman Z-Score | 2.74 |
SZSE:002099 Number of Guru Trades
SZSE:002099 Volume of Guru Trades
Gurus Latest Trades with SZSE:002099
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002099 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Zhejiang Hisoar Pharmaceutical Co Ltd Insider Transactions
No Available Data